Pharmacological Research (Apr 2024)

CircBIRC6 facilitates the malignant progression via miR-488/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer

  • Zhiyuan Tang,
  • Jieying Li,
  • Bing Lu,
  • Xiaojing Zhang,
  • Lei Yang,
  • Yue Qi,
  • Sutian Jiang,
  • Qianqian Wu,
  • Yingjing Wang,
  • Tong Cheng,
  • Manyu Xu,
  • Pingping Sun,
  • Xudong Wang,
  • Kai Miao,
  • Han Wu,
  • Jianfei Huang

Journal volume & issue
Vol. 202
p. 107127

Abstract

Read online

Circular RNAs (circRNAs) represent a novel class of non-coding RNAs that play significant roles in tumorigenesis and tumor progression. High-throughput sequencing of gastric cancer (GC) tissues has identified circRNA BIRC6 (circBIRC6) as a potential circRNA derived from the BIRC6 gene, exhibiting significant upregulation in GC tissues. The expression of circBIRC6 is notably elevated in GC patients. Functionally, it acts as a molecular sponge for miR-488, consequently upregulating GRIN2D expression and promoting GC proliferation, migration, and invasion. Moreover, overexpression of circBIRC6 leads to increased GRIN2D expression, which in turn enhances caveolin-1 (CAV1) expression, resulting in autophagy deficiency due to miR-488 sequestration. This cascade of events significantly influences tumorigenesis in vivo. Our findings collectively illustrate that the CircBIRC6-miR-488-GRIN2D axis fosters CAV1 expression in GC cells, thereby reducing autophagy levels. Both circBIRC6 and GRIN2D emerge as potential targets for treatment and independent prognostic factors for GC patients.

Keywords